Document Detail


HIV disease progression: depression, stress, and possible mechanisms.
MedLine Citation:
PMID:  12893105     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is much interest in whether depression and stress may explain the wide variability in the disease course of patients infected with human immunodeficiency virus (HIV). This article summarizes the large body of evidence examining whether depression and stress may have an impact on immune- and disease-related parameters in HIV disease. Furthermore, we review what is known about the underlying biological mechanisms of HIV disease, such as alterations in glucocorticoids and catecholamines, which may help explain these psychoimmune relationships. Our review of the literature finds substantial evidence that chronic depression and stressful events may affect HIV disease progression. We know little, however, regarding the biological mechanisms that may account for these relationships. More research is warranted to investigate how depression and stress might impact HIV disease progression and what types of interventions might mitigate the negative impact of chronic depression and trauma.
Authors:
Jane Leserman
Related Documents :
24406435 - Clinical significance of hbv precore and core promoter variants in korean patients with...
24058655 - Plasma concentrations of efavirenz and nevirapine among hiv-infected patients with immu...
20205035 - The effects of monitoring and ability to achieve cognitive structure on the psychologic...
11563235 - Assessment and treatment of hiv-related fatigue.
8387325 - Acute hepatitis c infection in patients undergoing therapy for haematological malignanc...
21460355 - Long-term resolution of viral breakthrough after changing hiv viral load assay.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Biological psychiatry     Volume:  54     ISSN:  0006-3223     ISO Abbreviation:  Biol. Psychiatry     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-08-01     Completed Date:  2003-09-26     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0213264     Medline TA:  Biol Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  295-306     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Catecholamines / metabolism
Depression / complications*,  immunology,  metabolism*
Disease Progression
Glucocorticoids / metabolism
HIV Infections / immunology,  metabolism*,  psychology
Humans
Stress, Psychological / complications*,  immunology,  metabolism*
Substance P / metabolism
Grant Support
ID/Acronym/Agency:
MH-33127/MH/NIMH NIH HHS; MH-44618/MH/NIMH NIH HHS; P30-HD37260/HD/NICHD NIH HHS; RR-00046/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Catecholamines; 0/Glucocorticoids; 33507-63-0/Substance P

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Depression in cancer: new developments regarding diagnosis and treatment.
Next Document:  Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease.